QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
Log in
NASDAQ:AMGN

Amgen News Headlines

$257.10
+3.60 (+1.42 %)
(As of 01/25/2021 12:00 AM ET)
Add
Compare
Today's Range
$251.85
Now: $257.10
$257.11
50-Day Range
$220.99
MA: $233.69
$253.50
52-Week Range
$177.05
Now: $257.10
$264.97
Volume1.68 million shs
Average Volume2.44 million shs
Market Capitalization$149.68 billion
P/E Ratio20.73
Dividend Yield2.52%
Beta0.76

Headlines

Amgen (NASDAQ AMGN) News Headlines Today

Source:
SourceHeadline
10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends
marketbeat.com - January 21 at 8:01 PM
10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends
marketbeat.com - January 20 at 8:01 PM
10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends
marketbeat.com - January 19 at 8:04 PM
Amgen (NASDAQ:AMGN) Price Target Raised to $285.00 at Morgan StanleyAmgen (NASDAQ:AMGN) Price Target Raised to $285.00 at Morgan Stanley
marketbeat.com - January 19 at 1:18 PM
10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends
marketbeat.com - January 18 at 8:25 PM
10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends
marketbeat.com - January 17 at 5:56 PM
10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends
marketbeat.com - January 17 at 5:55 PM
10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends
marketbeat.com - January 17 at 5:54 PM
10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends
marketbeat.com - January 16 at 5:27 PM
10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends
marketbeat.com - January 15 at 5:15 PM
10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends
marketbeat.com - January 14 at 5:01 PM
10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends
marketbeat.com - January 13 at 5:17 PM
10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends
marketbeat.com - January 12 at 5:11 PM
10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends
marketbeat.com - January 11 at 5:10 PM
10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends
marketbeat.com - January 11 at 5:04 PM
10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends
marketbeat.com - January 10 at 5:12 PM
10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends
marketbeat.com - January 9 at 5:08 PM
10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends
marketbeat.com - January 8 at 5:20 PM
Amgen (NASDAQ:AMGN) Now Covered by Analysts at Daiwa Capital MarketsAmgen (NASDAQ:AMGN) Now Covered by Analysts at Daiwa Capital Markets
marketbeat.com - December 29 at 7:09 AM
3 Biotech Stocks to Watch in December3 Biotech Stocks to Watch in December
marketbeat.com - December 1 at 5:22 PM
Top Stock Reports for NIKE, Amgen & Morgan StanleyTop Stock Reports for NIKE, Amgen & Morgan Stanley
finance.yahoo.com - January 25 at 6:00 PM
Worldwide Biosimilars Industry to 2026 - Key Players Include Amgen, AXXO and Biogen Among Others - Yahoo FinanceWorldwide Biosimilars Industry to 2026 - Key Players Include Amgen, AXXO and Biogen Among Others - Yahoo Finance
finance.yahoo.com - January 25 at 5:20 PM
The Week Ahead In Biotech (Jan 24-30): J&J, Lilly to Kickstart Big Pharma Earnings, Amgen FDA Decision and More - Yahoo FinanceThe Week Ahead In Biotech (Jan 24-30): J&J, Lilly to Kickstart Big Pharma Earnings, Amgen FDA Decision and More - Yahoo Finance
finance.yahoo.com - January 23 at 2:38 PM
The Week Ahead In Biotech (Jan 24-30): J&J, Lilly to Kickstart Big Pharma Earnings, Amgen FDA Decision and More - BenzingaThe Week Ahead In Biotech (Jan 24-30): J&J, Lilly to Kickstart Big Pharma Earnings, Amgen FDA Decision and More - Benzinga
benzinga.com - January 23 at 9:37 AM
World Autoinjectors Markets Report 2020-2027 Featuring Key Players - Amgen, Antares Pharma, Becton Dickinson and Co, Eli Lilly and Co, J&J, Mylan Novartis SHL Medical Teva Pharma & Ypsomed - Yahoo FinanceWorld Autoinjectors Markets Report 2020-2027 Featuring Key Players - Amgen, Antares Pharma, Becton Dickinson and Co, Eli Lilly and Co, J&J, Mylan Novartis SHL Medical Teva Pharma & Ypsomed - Yahoo Finance
finance.yahoo.com - January 22 at 11:08 PM
World Autoinjectors Markets Report 2020-2027 Featuring Key Players - Amgen, Antares Pharma, Becton Dickinson and Co, Eli Lilly and Co, J&J, Mylan Novartis SHL Medical Teva Pharma & Ypsomed - PRNewswireWorld Autoinjectors Markets Report 2020-2027 Featuring Key Players - Amgen, Antares Pharma, Becton Dickinson and Co, Eli Lilly and Co, J&J, Mylan Novartis SHL Medical Teva Pharma & Ypsomed - PRNewswire
prnewswire.com - January 22 at 2:07 PM
Worldwide Blood Cancer Drugs Industry to 2026 - Featuring Amgen, AstraZeneca and Astellas Pharma Among Others - PRNewswireWorldwide Blood Cancer Drugs Industry to 2026 - Featuring Amgen, AstraZeneca and Astellas Pharma Among Others - PRNewswire
prnewswire.com - January 20 at 4:02 PM
Why Amgen (AMGN) Could Beat Earnings Estimates Again - Yahoo FinanceWhy Amgen (AMGN) Could Beat Earnings Estimates Again - Yahoo Finance
finance.yahoo.com - January 20 at 4:02 PM
Why Amgen (AMGN) Could Beat Earnings Estimates AgainWhy Amgen (AMGN) Could Beat Earnings Estimates Again
finance.yahoo.com - January 20 at 4:02 PM
$6.61 Billion in Sales Expected for Amgen Inc. (NASDAQ:AMGN) This Quarter$6.61 Billion in Sales Expected for Amgen Inc. (NASDAQ:AMGN) This Quarter
americanbankingnews.com - January 20 at 1:56 AM
Motorhome Retirement: Amgen - Wait For A Better Price - Seeking AlphaMotorhome Retirement: Amgen - Wait For A Better Price - Seeking Alpha
seekingalpha.com - January 19 at 6:42 PM
Barron’s Investing Experts See ‘Low-Level Civil War,’ Hyper Stimulus, and Risks That Haven’t Yet Materialized for the Stock MarketBarron’s Investing Experts See ‘Low-Level Civil War,’ Hyper Stimulus, and Risks That Haven’t Yet Materialized for the Stock Market
finance.yahoo.com - January 19 at 5:28 PM
AMGN Stock: A Look At A Bullish Risk Reversal Option TradeAMGN Stock: A Look At A Bullish Risk Reversal Option Trade
finance.yahoo.com - January 19 at 5:28 PM
Amgen (NASDAQ:AMGN) PT Raised to $285.00Amgen (NASDAQ:AMGN) PT Raised to $285.00
americanbankingnews.com - January 19 at 2:14 PM
Amgen investing in Durham health data firm studying COVID-19 | Raleigh News & ObserverAmgen investing in Durham health data firm studying COVID-19 | Raleigh News & Observer
msn.com - January 16 at 3:17 PM
Welcome to the Roaring ’20s, but Maybe Not for StocksWelcome to the Roaring ’20s, but Maybe Not for Stocks
finance.yahoo.com - January 15 at 11:21 PM
CORRECTED-Health data firm Target RWE buys NoviSci in Amgen-backed deal - Yahoo FinanceCORRECTED-Health data firm Target RWE buys NoviSci in Amgen-backed deal - Yahoo Finance
finance.yahoo.com - January 15 at 1:29 AM
CORRECTED-Health data firm Target RWE buys NoviSci in Amgen-backed dealCORRECTED-Health data firm Target RWE buys NoviSci in Amgen-backed deal
finance.yahoo.com - January 14 at 8:28 PM
Amgen Inc. (NASDAQ:AMGN) Director Ronald D. Sugar Sells 1,000 SharesAmgen Inc. (NASDAQ:AMGN) Director Ronald D. Sugar Sells 1,000 Shares
americanbankingnews.com - January 14 at 6:48 PM
Health data firm Target RWE buys NoviSci in Amgen-backed deal - ReutersHealth data firm Target RWE buys NoviSci in Amgen-backed deal - Reuters
reuters.com - January 14 at 4:40 PM
Amgen and EVOQ Therapeutics ink development deal for autoimmune disordersAmgen and EVOQ Therapeutics ink development deal for autoimmune disorders
seekingalpha.com - January 13 at 7:41 AM
EVOQ Therapeutics Announces a License And Collaboration Agreement with Amgen - PRNewswireEVOQ Therapeutics Announces a License And Collaboration Agreement with Amgen - PRNewswire
prnewswire.com - January 13 at 7:38 AM
Amgen To Showcase Next Frontier Of Innovation In Lung Cancer Therapies At WCLC 2020 - PRNewswireAmgen To Showcase Next Frontier Of Innovation In Lung Cancer Therapies At WCLC 2020 - PRNewswire
prnewswire.com - January 12 at 1:56 PM
Gilead, Biogen Lead Biotechs That ‘Need to Do Deals’ for GrowthGilead, Biogen Lead Biotechs That ‘Need to Do Deals’ for Growth
finance.yahoo.com - January 12 at 11:57 AM
Amgen To Showcase Next Frontier Of Innovation In Lung Cancer Therapies At WCLC 2020Amgen To Showcase Next Frontier Of Innovation In Lung Cancer Therapies At WCLC 2020
finance.yahoo.com - January 12 at 11:57 AM
Amgen Inc. (AMGN) CEO Robert Bradway Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript) - Seeking AlphaAmgen Inc. (AMGN) CEO Robert Bradway Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript) - Seeking Alpha
seekingalpha.com - January 11 at 10:54 PM
Amgen To Present At J.P. Morgan Healthcare Conference; Webcast At 2:50 PM ET - NasdaqAmgen To Present At J.P. Morgan Healthcare Conference; Webcast At 2:50 PM ET - Nasdaq
nasdaq.com - January 11 at 10:54 PM
Amgen To Achieve Carbon Neutrality By 2027 - Yahoo FinanceAmgen To Achieve Carbon Neutrality By 2027 - Yahoo Finance
finance.yahoo.com - January 11 at 6:57 PM
GRAIL Announces Collaborations with Amgen, AstraZeneca, and Bristol Myers Squibb to Evaluate Cancer Early Detection Technology for Minimal Residual Disease - Yahoo FinanceGRAIL Announces Collaborations with Amgen, AstraZeneca, and Bristol Myers Squibb to Evaluate Cancer Early Detection Technology for Minimal Residual Disease - Yahoo Finance
finance.yahoo.com - January 11 at 5:54 PM
Amgen To Achieve Carbon Neutrality By 2027 - PRNewswireAmgen To Achieve Carbon Neutrality By 2027 - PRNewswire
prnewswire.com - January 11 at 5:54 PM
Amgen To Achieve Carbon Neutrality By 2027Amgen To Achieve Carbon Neutrality By 2027
finance.yahoo.com - January 11 at 5:54 PM
GRAIL Announces Collaborations with Amgen, AstraZeneca, and Bristol Myers Squibb to Evaluate Cancer Early Detection Technology for Minimal Residual Disease - Business WireGRAIL Announces Collaborations with Amgen, AstraZeneca, and Bristol Myers Squibb to Evaluate Cancer Early Detection Technology for Minimal Residual Disease - Business Wire
businesswire.com - January 11 at 9:03 AM
Amgen CEO Bradway on Vaccine Rollout, New Products - BloombergAmgen CEO Bradway on Vaccine Rollout, New Products - Bloomberg
bloomberg.com - January 7 at 7:44 PM
Moderna Hires Amgen Executive As Chief Commercial Officer To Bolster Vaccine Marketing - Yahoo FinanceModerna Hires Amgen Executive As Chief Commercial Officer To Bolster Vaccine Marketing - Yahoo Finance
finance.yahoo.com - January 7 at 7:44 PM
Moderna Hires Amgen Executive As Chief Commercial Officer To Bolster Vaccine MarketingModerna Hires Amgen Executive As Chief Commercial Officer To Bolster Vaccine Marketing
finance.yahoo.com - January 7 at 7:44 PM
Moderna hires Amgen executive as chief commercial officer - MarketWatchModerna hires Amgen executive as chief commercial officer - MarketWatch
marketwatch.com - January 7 at 2:44 PM
Worldwide Indsutry for KRAS Inhibitors to 2025 - Players Include Amgen, Mirati Therapeutics & Revolution Medicines Among Others - GlobeNewswireWorldwide Indsutry for KRAS Inhibitors to 2025 - Players Include Amgen, Mirati Therapeutics & Revolution Medicines Among Others - GlobeNewswire
globenewswire.com - January 7 at 9:38 AM
Amgen To Present At The 39th Annual J.P. Morgan Healthcare Conference - Yahoo FinanceAmgen To Present At The 39th Annual J.P. Morgan Healthcare Conference - Yahoo Finance
finance.yahoo.com - January 6 at 6:37 PM
Amgen To Present At The 39th Annual J.P. Morgan Healthcare ConferenceAmgen To Present At The 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 6 at 6:37 PM
Worldwide Indsutry for KRAS Inhibitors to 2025 - Players Include Amgen, Mirati Therapeutics & Revolution Medicines Among Others - Yahoo FinanceWorldwide Indsutry for KRAS Inhibitors to 2025 - Players Include Amgen, Mirati Therapeutics & Revolution Medicines Among Others - Yahoo Finance
finance.yahoo.com - January 6 at 1:37 PM
Amgens (AMGN) "Neutral" Rating Reaffirmed at Royal Bank of CanadaAmgen's (AMGN) "Neutral" Rating Reaffirmed at Royal Bank of Canada
americanbankingnews.com - January 4 at 6:52 AM
3 No-Brainer Stocks to Buy in Healthcare3 No-Brainer Stocks to Buy in Healthcare
finance.yahoo.com - January 1 at 8:36 AM
Dow Movers: CAT, AMGNDow Movers: CAT, AMGN
nasdaq.com - December 30 at 5:20 AM
DIA, HD, GS, AMGN: Large Outflows Detected at ETFDIA, HD, GS, AMGN: Large Outflows Detected at ETF
nasdaq.com - December 29 at 7:26 AM
Amgen’s Competition Heated Up in 2020. What’s Ahead for the Stock. - BarronsAmgen’s Competition Heated Up in 2020. What’s Ahead for the Stock. - Barron's
barrons.com - December 27 at 8:19 AM
Amgen: Now Is A Great Time To Buy This Cash Cow - Seeking AlphaAmgen: Now Is A Great Time To Buy This Cash Cow - Seeking Alpha
seekingalpha.com - December 24 at 7:59 AM
Amgen out-licenses tuberculosis/leprosy candidate to Medicines Development for Global Health - Seeking AlphaAmgen out-licenses tuberculosis/leprosy candidate to Medicines Development for Global Health - Seeking Alpha
seekingalpha.com - December 24 at 12:25 AM
Amgen Submits Sotorasib Marketing Authorization Application To The European Medicines Agency - Yahoo FinanceAmgen Submits Sotorasib Marketing Authorization Application To The European Medicines Agency - Yahoo Finance
finance.yahoo.com - December 24 at 12:25 AM
Amgen/AstraZenecas Asthma Drug Misses Phase III Study Goal - Yahoo FinanceAmgen/AstraZeneca's Asthma Drug Misses Phase III Study Goal - Yahoo Finance
finance.yahoo.com - December 23 at 1:42 PM
Amgen (AMGN) Files for KRAS Inhibitor for Lung Cancer in Europe - Yahoo FinanceAmgen (AMGN) Files for KRAS Inhibitor for Lung Cancer in Europe - Yahoo Finance
finance.yahoo.com - December 23 at 1:42 PM
This page was last updated on 1/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.